613
Views
69
CrossRef citations to date
0
Altmetric
REVIEWS

DHEA and intracrinology at menopause, a positive choice for evolution of the human species

&
Pages 205-213 | Received 02 Aug 2012, Accepted 22 Sep 2012, Published online: 05 Nov 2012

References

  • Archer DF. Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data. J Reprod Med. 2007;52(Suppl 2):159–64
  • Pines A, Sturdee DW, MacLennan AH, . The heart of the WHI study: time for hormone therapy policies to be revised. Climacteric 2007;10:267–9
  • Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065–79
  • WHO Scientific Group. Research on the Menopause in the 1990s. WHO technical report series No 866. Geneva: WHO, 1996
  • Labrie F. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy. Nature Clin Pract Endocrinol Metab 2007;3:584–93
  • Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol 2009;23:129–40
  • Simon JA, Reape KZ, Wininger S, Hait H. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healty postmenopausal women. Fertil Steril 2008;90:1132–8
  • Gold EB, Sternfeld B, Kelsey JL, . Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 2000;152:463–73
  • Anderson E, Hamburger S, Liu JH, Rebar RW. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol 1987;156:428–33
  • Williams RE, Levine KB, Kalilani L, Lewis J, Clark RV. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas 2009;62:153–9
  • NAMS Professional Education Committee. Overview of menopause and aging. In Menopause Practice: A Clinician’s Guide. Mayfield Heights (OH): The North American Menopause Society, 2007:9–17
  • Pollycove R, Naftolin F, Simon JA. The evolutionary origin and significance of menopause. Menopause 2011;18:336–42
  • Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231–7
  • Austad SN. Menopause: an evolutionary perspective. Exp Gerontol 1994;29:255–63
  • Hamilton WD. The moulding of senescence by natural selection. J Theor Biol 1966;12:12–45
  • Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957;11:398–411
  • Lahdenpera M, Lummaa V, Russell AF. Menopause: why does fertility end before life? Climacteric 2004;7:327–31
  • Sear R, Mace R, McGregor IA. Maternal grandmothers improve nutritional status and survival of children in rural Gambia. Proc Biol Sci 2000;267:1641–7
  • Voland E, Beise J. Opposite Effects of maternal and paternal grandmothers on infant survival in historical Krummhörn. Behav Ecol Sociobiol 2002;52:435–43
  • Hawkes KJ, O’Connell F, Blurton Jones NG. Hadza women’s time allocation, offspring provisioning, and the evolution of long postmenopausal life spans. Curr Anthropol 1997;38: 551–77
  • Jolly M, Sebire N, Harris J, Robinson S, Regan L. The risks associated with pregnancy in women aged 35 years or older. Hum Reprod 2000;15:2433–7
  • Gaulden ME. Maternal age effect: the enigma of Down syndrome and other trisomic conditions. Mutat Res 1992;296:69–88
  • Wood JW. Dynamics of Human Reproduction: Biology, Biometry, Demography. New York: Aldine De Gruyter, 1994
  • Lahdenpera M, Lummaa V, Helle S, Tremblay M, Russell AF. Fitness benefits of prolonged post-reproductive lifespan in women. Nature 2004;428:178–81
  • Jamison CS, Cornell LL, Jamison PL, Nakazato H. Are all grandmothers equal? A review and a preliminary test of the ‘grandmother hypothesis’ in Tokugawa Japan. Am J Phys Anthropol 2002;119:67–76
  • Svejme O, Ahlborg H, Nilsson JA, Karlsson M. Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women. BJOG 2012;119: 810–16
  • Rivera CM, Grossardt BR, Rhodes DJ, . Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009;16:15–23
  • Ossewaarde ME, Bots ML, Verbeek AL, . Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005;16:556–62
  • Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161–6
  • Colditz GA, Willett WC, Stampfer MJ, . Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105–10
  • Falkeborn M, Schairer C, Naessen T, Persson I. Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol 2000;53:832–7
  • Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006;13:265–79
  • Parker WH, Broder MS, Liu Z, . Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005;106:219–26
  • Labrie F, Martel C, Balser J. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary? Menopause 2011;18:30–43
  • Hawkes K. Human longevity: the grandmother effect. Nature 2004;428:128–9
  • Corner GW. Ovulation and menstruation in Macacus rhesus. Contrib Embryol Carnegie Inst 1923;15:73–102
  • Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey. J Steroid Biochem Molecul Biol 2002;81:159–64
  • Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey. J Clin Endocrinol Metab 2003; 88:4293–302
  • Martel C, Melner MH, Gagné D, Simard J, Labrie F. Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/D5-D4 isomerase (3β-HSD), 17β-HSD 5α-reductase and aromatase activities in the rhesus monkey. Mol Cell Endocrinol 1994;104:103–11
  • Gilardi KV, Shideler SE, Valverde CR, Roberts JA, Lasley BL. Characterization of the onset of menopause in the rhesus macaque. Biol Reprod 1997;57:335–40
  • Kavanagh K, Koudy Williams J, Wagner JD. Naturally occurring menopause in cynomolgus monkeys: changes in hormone, lipid, and carbohydrate measures with hormonal status. J Med Primatol 2005;34:171–7
  • Nichols SM, Bavister BD, Brenner CA, . Ovarian senescence in the rhesus monkey (Macaca mulatta). Hum Reprod 2005; 20:79–83
  • Bellino FL, Wise PM. Nonhuman primate models of menopause workshop. Biol Reprod 2003;68:10–18
  • Appt SE, Ethun KF. Reproductive aging and risk for chronic disease: Insights from studies of nonhuman primates. Maturitas 2010;67:7–14
  • Appt SE, Clarkson TB, Hoyer PB, . Experimental induction of reduced ovarian reserve in a nonhuman primate model (Macaca fascicularis). Comp Med 2010;60:380–8
  • Marsh H, Kasuya T. Evidence for reproductive senescence in female cateceans. Rep Int Whal Commn 1986;8:57–75
  • Kasuya T, Marsh H. Life history and reproductive biology of the short-finned pilot whale, Globicephala macrorhynchus, off the Pacific Coast of Japan. Rep Int Whal Commn 1984;6:259–310
  • Census Browser University of Virginia. Geospatial and Statistical Data Center. Available at: http://fisher.lib.virginia.edu/collections/stats/hist-census/index.html. April 25
  • Emery Thompson M, Jones JH, Pusey AE, . Aging and fertility patterns in wild chimpanzees provide insights into the evolution of menopause. Curr Biol 2007;17:2150–6
  • Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol 1979;133:537–47
  • Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975;293:1164–7
  • The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1996;275:370–5
  • Longcope C, Franz C, Morello C, Baker R, Johnston CC Jr. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 1986;8:189–96
  • Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JC. A prospective longitudinal study of serum testosterone dehydroepiandrosterone sulfate and sex hormone binding globulin levels through the menopause transition. J Clin Endocrin Metab 2000;85:2832–8
  • Rannevik G, Jeppsson S, Johnell O, . A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995;21:103–13
  • Labrie F. DHEA after menopause – sole source of sex steroids and potential sex steroid deficiency treatment. Menopause Management 2010;19:14–24
  • Labrie C, Bélanger A, Labrie F. Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 1988;123:1412–17
  • Labrie F, Dupont A, Bélanger A. Complete androgen blockade for the treatment of prostate cancer. In de Vita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. Philadelphia: J.B. Lippincott, 1985:193–217
  • Baker ME. Co-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors. Mol Cell Endocrinol 2004;215:55–62
  • Labrie F. Intracrinology. Mol Cell Endocrinol 1991;78:C113–18
  • Labrie F, Luu-The V, Bélanger A, . Is DHEA a hormone? Starling Review. J Endocrinol 2005;187:169–96
  • Luu-The V. Assessment of steroidogenic pathways that do not require testosterone as intermediate. Horm Mol Biol Clin Invest 2011;5:161–5
  • Labrie C, Simard J, Zhao HF, . Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 1989;124:2745–54
  • Labrie F, Simard J, Luu-The V, Bélanger A, Pelletier G. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J Steroid Biochem Mol Biol 1992;43:805–26
  • Labrie F, Sugimoto Y, Luu-The V, . Structure of human type II 5α-reductase gene. Endocrinology 1992;131:1571–3
  • Labrie Y, Durocher F, Lachance Y, . The human type II 17β-hydroxysteroid dehydrogenase gene encodes two alternatively-spliced messenger RNA species. DNA Cell Biol 1995;14:849–61
  • Luu-The V, Zhang Y, Poirier D, Labrie F. Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: oxidation-reduction and inhibition. J Steroid Biochem Mol Biol 1995;55:581–7
  • Labrie F, Simard J, Luu-The V, . The 3β-hydroxysteroid dehydrogenase/isomerase gene family: lessons from type II 3β-HSD congenital deficiency. Signal Transduction in Testicular Cells, Ernst Schering Research Foundation Workshop 1996;Suppl 2:185–218
  • Labrie F, Luu-The V, Lin SX, . The key role of 17β-HSDs in sex steroid biology. Steroids 1997;62:148–58
  • Labrie F, Bélanger A, Bélanger P, . Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 2006;99:182–8
  • Labrie F, Luu-The V, Labrie C, . Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrine Rev 2003;24:152–82
  • Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396–402
  • Ethun KF, Wood CE, Parker CR Jr, . Effect of ovarian aging on androgen biosynthesis in a cynomolgus macaque model. Climacteric 2012;15:82–92
  • Labrie F, Diamond P, Cusan L, . Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997;82:3498–505
  • Baxendale PM, Reed MJ, James VH. Inability of human endometrium or myometrium to aromatize androstenedione. J Steroid Biochem 1981;14:305–6
  • Bulun SE, Lin Z, Imir G, . Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005;57:359–83
  • Simpson ER, Mahendroo MS, Means GD, . Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Res 1994;15:342–55

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.